Literature DB >> 15358711

European framework to decrease the burden of TB/HIV.

P de Colombani1, N Banatvala, R Zaleskis, D Maher.   

Abstract

Tuberculosis (TB) in Europe is declining in countries in western and central Europe, but the burden is still high and increasing in eastern Europe. HIV/AIDS is increasing dramatically in eastern Europe. HIV-related tuberculosis (TB/HIV) morbidity and mortality are expected to accelerate significantly in the future. This framework aims to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. It results from an extensive consultation process undertaken by the World Health Organization Regional Office for Europe and by those responsible for HIV/AIDS and TB programmes and their partners. It builds on strategies developed globally and in Europe for TB control and for HIV/AIDS prevention and care. This framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programmes. It identifies five strategic components (political commitment, collaborative prevention, intensified case-finding, coordinated treatment and strengthened surveillance) and eight key operations (central coordination, policy development, surveillance, training, supply management, service delivery, health promotion and research).

Entities:  

Mesh:

Year:  2004        PMID: 15358711     DOI: 10.1183/09031936.04.00064504

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Knowledge and misconceptions of tuberculosis in the general population in Serbia.

Authors:  D Vukovic; L Nagorni-Obradovic; V Bjegovic
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-04-10       Impact factor: 3.267

2.  Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients.

Authors:  M F Fleming; E Krupitsky; M Tsoy; E Zvartau; N Brazhenko; W Jakubowiak; M E McCaul
Journal:  Int J Tuberc Lung Dis       Date:  2006-05       Impact factor: 2.373

3.  Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.

Authors:  Massimo Cogliati; Roberta D'Amicis; Alberto Zani; Maria Teresa Montagna; Giuseppina Caggiano; Osvalda De Giglio; Stella Balbino; Antonella De Donno; Francesca Serio; Serdar Susever; Cagri Ergin; Aristea Velegraki; Mohamed S Ellabib; Simona Nardoni; Cristina Macci; Salvatore Oliveri; Laura Trovato; Ludovico Dipineto; Volker Rickerts; Ilka McCormick-Smith; Sevim Akcaglar; Okan Tore; Emilija Mlinaric-Missoni; Sebastien Bertout; Michele Mallié; Maria da Luz Martins; Ana C F Vencà; Maria L Vieira; Ana C Sampaio; Cheila Pereira; Giuseppe Criseo; Orazio Romeo; Stéphane Ranque; Mohammed H Y Al-Yasiri; Meltem Kaya; Nilgun Cerikcioglu; Anna Marchese; Luigi Vezzulli; Macit Ilkit; Marie Desnos-Ollivier; Vincenzo Pasquale; Maya Korem; Itzhack Polacheck; Antonio Scopa; Wieland Meyer; Kennio Ferreira-Paim; Ferry Hagen; Bart Theelen; Teun Boekhout; Shawn R Lockhart; Kathrin Tintelnot; Anna Maria Tortorano; Françoise Dromer; Ashok Varma; Kyung J Kwon-Chung; Joäo Inácio; Beatriz Alonso; Maria F Colom
Journal:  FEMS Yeast Res       Date:  2016-05-05       Impact factor: 2.796

4.  HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.

Authors:  Lena Fiebig; Christian Kollan; Barbara Hauer; Barbara Gunsenheimer-Bartmeyer; Matthias An der Heiden; Osamah Hamouda; Walter Haas
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  European union standards for tuberculosis care.

Authors:  G B Migliori; J P Zellweger; I Abubakar; E Ibraim; J A Caminero; G De Vries; L D'Ambrosio; R Centis; G Sotgiu; O Menegale; K Kliiman; T Aksamit; D M Cirillo; M Danilovits; M Dara; K Dheda; A T Dinh-Xuan; H Kluge; C Lange; V Leimane; R Loddenkemper; L P Nicod; M C Raviglione; A Spanevello; V Ø Thomsen; M Villar; M Wanlin; J A Wedzicha; A Zumla; F Blasi; E Huitric; A Sandgren; D Manissero
Journal:  Eur Respir J       Date:  2012-04       Impact factor: 16.671

6.  Factors associated with tuberculosis as an AIDS-defining disease in an immigration setting.

Authors:  Vicente Martín; Patricia García de Olalla; Angels Orcau; Joan A Caylà
Journal:  J Epidemiol       Date:  2011-02-12       Impact factor: 3.211

7.  Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.

Authors:  Tandakha N Dieye; Birahim P Ndiaye; Alle B Dieng; Marema Fall; Nathaniel Brittain; Nathaniel Britain; Samantha Vermaak; Makhtar Camara; Halimatou Diop-Ndiaye; Ndeye Fatou Ngom-Gueye; Papa A Diaw; Coumba Toure-Kane; Papa S Sow; Souleymane Mboup; Helen McShane
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

8.  Training of front-line health workers for tuberculosis control: lessons from Nigeria and Kyrgyzstan.

Authors:  Niyi Awofeso; Irina Schelokova; Abubakar Dalhatu
Journal:  Hum Resour Health       Date:  2008-09-29

9.  Tuberculosis incidence in HIV/AIDS patients in Israel, 1983-2010.

Authors:  Zohar Mor; Moshe Lidji; Noa Cedar; Itamar Grotto; Daniel Chemtob
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.